Renal cancer detection method and test drug
AssigneesPublic University Corporation Yokohama City University, Tosoh Corporation
InventorsNoriaki ARAKAWA, Hisashi HIRANO, Noboru NAKAIGAWA, Masahiro YAO, Norihisa OHTAKE
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide a method for detecting renal cancer, and a reagent that can be used for the method. Provided is a method for detecting renal cancer, which includes measuring the amount of TFPI2 in a sample derived from a patient. An antibody that specifically recognizes NT-TFPI2 and intact TFPI2 is included in a detection reagent for renal cancer.
Claims7
A method for detecting renal cancer, said method comprising measuring the amount of TFPI2 in a sample.
A reagent for detecting renal cancer, comprising an antibody that binds to an antigenic determinant in the region from the 23th residue aspartic acid to the 131st residue histidine or to the 130th residue cysteine in the amino acid sequence of SEQ ID NO:1.
Dependencies are inferred from the claim text.